MU-iCATS
Leadership
Research Office
Compliance & Quality
Grants & Contracts
Biostatistics
Clinical Trials
Centers/Facilities
Seminars
Resources
RFA Notices
Training
MU-iCATS Faculty Members
Douglas C. Anthony,
MD, PhD
Professor & Chairman Dept of Pathology & Anatomical Sciences, Co-Investigator MU-iCATS Douglas C. Anthony, MD, PhD, is responsible for the leadership and administration of MU-iCATS educational programs, including the advanced degrees (MS and PhD) in clinical and translational science, the pre-doctoral traineeship (T32), the pre-doctoral fellowship (T90), the faculty career development program (K12), and the “pipeline” and diversity programs.
Dr. Anthony is Professor and Chair of Pathology and Anatomical
Sciences and Director of the MD-PhD Program; he obtained his MD and PhD in the Duke
Medical Science Training Program, and he has extensive experience in mentoring and
training students at the interface between clinical medicine and basic sciences.
Dr. Anthony has supervised the research of graduate and medical students, post-doctoral
and clinical fellows, served as Associate Director of the Medical Scientist Training
Program, MD-PhD, at Duke University; he also helped revise medical curricula at
Harvard Medical School and at the University of Missouri-Columbia. He has authored
chapters in preeminent textbooks in medical education (Robbins and Cotran’s Pathologic
Basis of Disease, 5th -7th eds, 8th edition in press) and basic science education
(Casarett and Doull’s Toxicology: The Basic Science of Poisons, 4th -6th eds). Dr.
Anthony has been involved in admission, curriculum revision, and steering committees
at Duke, Harvard, and the University of Missouri-Columbia medical schools. He has
received numerous teaching awards from both students and faculty, including the
prestigious faculty-selected Miyawaki Award at Harvard Medical School as the best
faculty teacher in neurosciences.
Dr. Anthony is a collaborative investigator in
several areas related to neuropathology, most notably neoplasia of the nervous system
and neurotoxicology. Work in his laboratory was the first to define the relationship
between the desmoplastic variant of medulloblastoma and the PTCH gene, located on
9q22.3, by recognizing that patients with Gorlin's syndrome (basal cell nevus syndrome)
develop this variant of medulloblastoma, and extending the relationship through
LOH studies to the entire category of desmoplastic medulloblastomas. Dr. Anthony
is currently working on the pathobiology of brain tumors, including the molecular
basis for spectral signals in clinical MR spectroscopy, epigenetics of brain tumors,
and cell-cell binding in metastasis.
Back to MU-iCATS Faculty Members
Professor & Chairman Dept of Pathology & Anatomical Sciences, Co-Investigator MU-iCATS Douglas C. Anthony, MD, PhD, is responsible for the leadership and administration of MU-iCATS educational programs, including the advanced degrees (MS and PhD) in clinical and translational science, the pre-doctoral traineeship (T32), the pre-doctoral fellowship (T90), the faculty career development program (K12), and the “pipeline” and diversity programs.
Dr. Anthony is Professor and Chair of Pathology and Anatomical
Sciences and Director of the MD-PhD Program; he obtained his MD and PhD in the Duke
Medical Science Training Program, and he has extensive experience in mentoring and
training students at the interface between clinical medicine and basic sciences.
Dr. Anthony has supervised the research of graduate and medical students, post-doctoral
and clinical fellows, served as Associate Director of the Medical Scientist Training
Program, MD-PhD, at Duke University; he also helped revise medical curricula at
Harvard Medical School and at the University of Missouri-Columbia. He has authored
chapters in preeminent textbooks in medical education (Robbins and Cotran’s Pathologic
Basis of Disease, 5th -7th eds, 8th edition in press) and basic science education
(Casarett and Doull’s Toxicology: The Basic Science of Poisons, 4th -6th eds). Dr.
Anthony has been involved in admission, curriculum revision, and steering committees
at Duke, Harvard, and the University of Missouri-Columbia medical schools. He has
received numerous teaching awards from both students and faculty, including the
prestigious faculty-selected Miyawaki Award at Harvard Medical School as the best
faculty teacher in neurosciences.
Dr. Anthony is a collaborative investigator in
several areas related to neuropathology, most notably neoplasia of the nervous system
and neurotoxicology. Work in his laboratory was the first to define the relationship
between the desmoplastic variant of medulloblastoma and the PTCH gene, located on
9q22.3, by recognizing that patients with Gorlin's syndrome (basal cell nevus syndrome)
develop this variant of medulloblastoma, and extending the relationship through
LOH studies to the entire category of desmoplastic medulloblastomas. Dr. Anthony
is currently working on the pathobiology of brain tumors, including the molecular
basis for spectral signals in clinical MR spectroscopy, epigenetics of brain tumors,
and cell-cell binding in metastasis.
Back to MU-iCATS Faculty Members
